AmeriFlex Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

AmeriFlex Group’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-160	Closed	-$21.1K	–	1305
2025 Q1	$21.1K	Hold	160	–	–	0.01%	679
2024 Q4	$20.3K	Buy	+160	New	+$13.1K	0.01%	620

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AmeriFlex Group's ITCI Position: Q2 2025 in Review

AmeriFlex Group sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 160 shares — an estimated $21.1K sold.

AmeriFlex Group first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $21.1K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

AmeriFlex Group reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
AmeriFlex Group sold 160 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $21.1K.
AmeriFlex Group first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
AmeriFlex Group's Intra-Cellular Therapies Inc. position peaked at $21.1K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on AmeriFlex Group's 13F filing for Q2 2025, filed 21 Jul 2025.